Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019774

FDA
02 Apr 2024
Genexine's weekly growth hormone equal to Novo shot in phase 3
Genexine's weekly growth hormone equal to Novo shot in phase 3

31 Aug 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/genexines-weekly-growth-hormone-equal-novo-shot-phase-3-teeing-filing-china

Nick Paul Taylor FIERCE BIOTECH
31 Aug 2023

https://endpts.com/novo-nordisk-remains-under-uk-scrutiny-as-mhra-conducts-its-own-review-in-incredibly-rare-case/

Beth Snyder Bulik ENDPTS
21 Mar 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021426

FDA
25 Jan 2022
Pfizer stumbles close to finish line in growth hormone race
Pfizer stumbles close to finish line in growth hormone race

27 Sep 2021

// Nick Paul Taylor FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/pfizer-stumbles-close-to-finish-line-growth-hormone-race-extending-lead-rival-ascendis

Nick Paul Taylor FIERCEBIOTECH
27 Sep 2021

https://endpts.com/pfizer-gets-some-encouraging-phiii-news-on-a-franchise-savior-but-is-a-dosing-advantage-worth-the-295m-upfront/

John Carroll ENDPTS
22 Oct 2019